Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Clinical Pharmacokinetics|September 6, 2015
Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic MalignanciesElodie Odore, François Lokiec, Esteban Cvitkovic, et al.
British Journal of Haematology|November 9, 2018
The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adultsAurélie Cabannes-Hamy, Nicolas Boissel, Régis Peffault De Latour, et al.
Cancer|May 25, 2005
Acute leukemia during pregnancy: a report on 37 patients and a review of the literatureYoucef Chelghoum, Norbert Vey, Emmanuel Raffoux, et al.
Oncotarget|May 21, 2015
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cellsMarie-Magdelaine Coudé, Thorsten Braun, Jeannig Berrou, et al.
Blood|July 28, 2005
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotypeNicolas Boissel, Aline Renneville, Valeria Biggio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2014
Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trialsJean Baptiste Micol, Emmanuel Raffoux, Nicolas Boissel, et al.
Leukemia Research|December 3, 2014
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failureSylvain Thepot, Simone Boehrer, Valérie Seegers, et al.
Open Forum Infectious Diseases|August 26, 2024
Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in FranceBlandine Denis, Matthieu Resche-Rigon, Emmanuel Raffoux, et al.
Pageof 17